Codexis, Inc. - Common Stock (NQ:CDXS)

1.220 -0.040 (-3.17%)

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Codexis, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Earnings Scheduled For May 14, 2025 ↗

May 14, 2025

Via Benzinga

Preview: Codexis's Earnings ↗

May 13, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 29, 2024

Via Benzinga

Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 27, 2024

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Deep Dive Into Codexis Stock: Analyst Perspectives (4 Ratings) ↗

November 22, 2024

Via Benzinga

Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors

October 22, 2024

From Artiva Biotherapeutics, Inc.

Via GlobeNewswire

CDXS Stock Earnings: Codexis Misses EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

CDXS stock results show that Codexis missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

CDXS Stock Earnings: Codexis Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

CDXS stock results show that Codexis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Recap: Codexis Q4 Earnings ↗

February 28, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 27, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 27, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

February 01, 2024

Via Benzinga

Codexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthrough ↗

December 27, 2023

Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI).

Via Benzinga

“Dyadic International Inc. (NASDAQ: DYAI) Advances Biopharmaceutical Innovations and Vaccine Manufacturing Globally”

December 21, 2023

Via AB Newswire

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

December 14, 2023

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 14, 2023

Via Benzinga

Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket ↗

December 14, 2023

Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining investment in Lynx Motors. Nxu, shares rose 42.1% to $0.0278 in pre-market...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 13, 2023

Via Benzinga

3 Synthetic Biology Stocks Likely to Mint New Millionaires ↗

November 29, 2023

Synthetic biology stocks are strongly worth considering for several reasons, particularly these three stocks.

Via InvestorPlace

The Next Nvidia: 3 AI Stocks That Could Break New Records ↗

September 16, 2023

While trying to find the next Nvidia is a wildly risky proposition, these AI stocks to buy could be your ticket to extraordinary gains.

Via InvestorPlace

Topics Artificial Intelligence

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 12, 2023

Via Benzinga

Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M ↗

August 22, 2023

Via Benzinga

Topics Earnings

Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company's Stock Instead ↗

August 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 14, 2023

Via Benzinga

Codexis' Strategic Focus: Discontinues Biotherapeutics Development, Lays Off 25% Of Employees, Cash Runway Into Mid-2026 ↗

July 21, 2023

Codexis Inc (NASDAQ: CDXS) intends to prioritize advancing and commercializing its Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis platform and its

Via Benzinga

Cathie Wood's Ark Invest Makes Major Quantum-Si Purchase — Loads Up On 1.4M Shares Of Semiconductor Firm ↗

July 13, 2023

Via Benzinga

Cathie Wood's Ark Invest Continues Tesla Selling Spree Despite Stock's Rise, AI Potential ↗

July 12, 2023

Via Benzinga

Time to Evolve: 3 Synthetic Biology Stocks to Sell Off Now ↗

July 08, 2023

The biotech boom has become a biotech bust. Many companies still have further to fall, so sell these three before they hit rock bottom.

Via InvestorPlace

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.